Mesoblast Limited (MESO): Price and Financial Metrics
MESO Price/Volume Stats
| Current price | $10.33 | 52-week high | $12.18 |
| Prev. close | $10.82 | 52-week low | $1.61 |
| Day low | $10.08 | Volume | 216,300 |
| Day high | $10.49 | Avg. volume | 760,416 |
| 50-day MA | $8.81 | Dividend yield | N/A |
| 200-day MA | $6.50 | Market Cap | 1.18B |
MESO Stock Price Chart Interactive Chart >
Mesoblast Limited (MESO) Company Bio
Mesoblast Ltd. has established a diverse portfolio of product candidates based on its proprietary allogeneic, off-the-shelf mesenchymal lineage cell-based technology, with multiple active Phase 3 clinical programs. Mesoblast's lead product candidates target major diseases with significant unmet medical needs despite existing therapies. These include chronic heart failure, chronic low back pain due to degenerative disc disease, and immune-mediated conditions such as acute graft versus host disease and biologic refractory rheumatoid arthritis. The company is based in Melbourne, Australia.
MESO Price Returns
| 1-mo | 9.49% |
| 3-mo | 57.47% |
| 6-mo | 26.44% |
| 1-year | 285.45% |
| 3-year | -17.36% |
| 5-year | -14.34% |
| YTD | 369.55% |
| 2023 | -62.20% |
| 2022 | -39.38% |
| 2021 | -43.46% |
| 2020 | 15.20% |
| 2019 | 78.88% |
Continue Researching MESO
Here are a few links from around the web to help you further your research on Mesoblast Ltd's stock as an investment opportunity:Mesoblast Ltd (MESO) Stock Price | Nasdaq
Mesoblast Ltd (MESO) Stock Quote, History and News - Yahoo Finance
Mesoblast Ltd (MESO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...